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Background: Human Rhinoviruses (HRV) are major causative agents of acute respiratory tract infections in all age
group and important contributing factors of childhood morbidity and mortality. Clinical presentation is poorly
specific and the great antigenic and genetic variability of HRVs renders the biological diagnosis complex. Here,
we have evaluated several molecular diagnostic protocols, including Taqman probe-based and intercalating
agent-based RT-PCR assays.
Methods: 5,627 respiratory samples sent to the laboratory of Virology of the University Hospitals of Marseille,
France, from March 2011 to February 2012, were tested using a real-time RT-PCR assay in the 5’NCR of the rhinoviral
genome that associated a Taqman probe and the detection of DNA-BOXTO-dye complexes. A sample of 500
BOXTO-positive samples were further tested using the same probe assay (without BOXTO), and a SYBR Green assay
(using the same amplification primers). The specific amplification of HRV sequences was assessed by NGS amplicon
sequencing.
Results: The Taqman probe RT-PCR assay identified 696/5,627 samples (12,4%) as HRV-positive. BOXTO-positive
samples included all probe-positive samples and 1,913 additional samples, of which only 24.3% were confirmed by
sequencing. The SYBR Green assay was more specific (16/550 samples were probe-negative/SYBR Green-positive, all
confirmed by 5′NCR sequencing), but 3/500 samples were probe-positive/SYBR Green-negative.
Conclusions: Our results highlight the difficulty in detecting HRVs in clinical samples using a single molecular
detection system. Amongst the 3 systems tested, the best compromise was obtained with the SYBR Green assay,
which, by comparison with our probe-based assay provided an improved sensitivity without altering the detection
specificity. Interestingly, a majority of probe-negative/BOXTO- or SYBR Green-positive samples were not associated
with mutations in the sequence targeted by the probe. Sequence-based modifications of the secondary structure of
the HRV 5′NCR may be associated with a limited access to the probe hybridisation region. Further investigations
may identify a test combining a probe based- and an intercalating agent-based detection, which will significantly
improve the diagnosis of HRV infections.
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Acute respiratory tract infections (ARIs) represent a
major public health problem worldwide, a leading cause
of human acute illnesses and an important contributing
factor of childhood morbidity and mortality, especially
in children under 5 years [1-3]. A majority of ARIs in
children have a viral etiology, probably due to absent or
incomplete immune protection, sustained viral shedding
and high transmissibility amongst hosts [4]. Amongst a var-
iety of RNA and DNA viruses that can infect the respiratory
tract, Human Rhinoviruses (Picornaviridae family) [5], are
recognized as the most prevalent in all age group world-
wide [6]. Together with coronaviruses, they represent com-
mon causative agents of upper respiratory tract (URT)
infections, traditionally defined as common cold [6,7], and
thus a major cause of school and work absenteeism since
children experience 8–12 and adults 2–3 URT episodes per
year, on average [8]. Children are the major reservoir for
HRV [9]. The mean age at the first symptomatic HRV in-
fection is 4–6 months (vs >6 months for other viruses such
as RSV [10]; more than 90% of children have experienced
at least one HRV infection by the age of 2 years [11]. HRV
infection is most often associated with a non-specific, self-
limiting illness with clinical manifestations ranging from an
asymptomatic presentation to fever, rhinorrhea, cough and
wheezing. However, HRV infections are increasingly in-
volved in otitis media, pneumonia, or chronic obstructive
pulmonary disease, especially in infants, elderly and im-
munocompromised patients [12,13]. In addition, HRV rep-
resent a major viral aetiology of asthma exacerbations, with
the highest incidence of all respiratory viruses in adults and
children >2 years of age (60–65% of viral exacerbations)
[14,15]. Although suspected in some studies, there is at the
present day no proof of association between clinical severity
and HRV species [16-20]. Altogether, these data highlight
the predominant role of HRV as a respiratory pathogen es-
pecially in early life.
HRVs are small non-enveloped viruses with a single-
stranded RNA genome of positive polarity; originally
classified in the Rhinovirus genus, they have been inte-
grated into the Enterovirus genus. Rhinoviruses share
with Enteroviruses an identical genomic organization
and have similar functional RNA secondary structures,
but differ in their acid tolerance, receptor usage, and cell
tropism [21]. The genome is approximately 7.2 kb long,
and is composed of a 5′non-coding region (5′NCR),
followed by a long open reading frame coding for four
structural icosahedral capsid proteins (VP4, VP2, VP3
and VP1), and seven non-structural proteins 2A, 2B, 2C,
3A, 3B, 3C and 3D, and terminated by a short 3′UTR
and poly A tract. HRVs are highly heterogeneous genetic-
ally and antigenically [22,23]. More than 140 serotypes
have been described, and these fall into three species, HRV
species A (HRV-A; 74 serotypes), HRV-B (25 serotypes)and a novel genetically distinct third genotype HRV-C,
comprising 49 designated serotypes recognized in
2006 [24-27].
HRV infections occur throughout the year [28], usually
with peaks in spring and autumn in temperate countries
[29-31], the prevalence varying from 10% to 60% de-
pending on the population or the period studied. Mo-
lecular studies suggest almost equal prevalence of HRVA
and HRVC, with a under-representation of HRVB spe-
cies [11,19,32-39]. A remarkably wide genetic diversity
of HRV serotypes can be observed all year long [40].
The diagnosis of HRV infections is important for epi-
demiological purposes but also for optimising the med-
ical management of patients (e.g., the opportunity for an
antibiotic treatment). As clinical presentation is non-
specific, it devolves to the diagnostic laboratory to con-
firm the presence of HRVs [41]. Detection of HRV by
culture is slow and complex for HRVA and HRVB,
whilst HRVC has been unculturable in vitro to date [23].
Serologic diagnosis is virtually impossible due to the
number of serotypes, and rapid antigen test kits are not
available [4]. Molecular methods such as real-time RT-
PCR appear to be the most suitable method, combining
short analysis time, high sensitivity, semi-quantification
of viral load and the detection of the majority of respira-
tory viruses with multiplex methods [42-44]. Most of the
published systems target the 5′NCR. However, the high
genetic diversity of HRVs makes the detection of all vari-
ants difficult as evidenced by the alignment of available
GenBank 5′NCR sequences. Indeed, a comparison of
published HRV-specific PCR primers pairs showed that
no single pair could detect all HRVs [45] and that more
than one PCR is required for accurate description of
HRV epidemiology.
The range of detection of HRV variants by a probe-
based real-time PCR assay is predicted to be additionally
restricted by mutations in the region of the probe. Ac-
cordingly, we have compared the performances of 3 tests
for accurately detecting HRV in clinical samples: (i) a
probe-based Taqman RT-PCR assay routinely used in
our hospital laboratory; (ii) the same test used without
the probe and in the presence of SYBR Green I, making
theoretically possible to diagnose HRVs amplified by the
primers but not detected by the probe; (iii) the same test
used with both the probe and in the presence of the
BOXTO intercalating agent, making theoretically pos-
sible to detect HRV detected and undetected by the
probe in the same reaction.
Methods
Clinical Samples
5,627 samples (nasopharyngeal aspirates, swabs or saliva
specimens) sent to the Laboratory of Virology, University
Hospital La Timone (Marseille, France) from March 2011
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were studied. They were predominantly from hospital in-
patients or patients in emergency departments, who pre-
sented with respiratory symptoms.
All samples were analysed using real-time RT-PCR assay
using an association of a specific-probe and BOXTO. 500
samples randomly chosen amongst those with a positive
BOXTO result (see below) were secondarily tested using
(i) the same specific-probe without BOXTO, and (ii) a
SYBR Green assay.
RNA extraction
Each sample (200 μL) was spiked by a mix of T4 and
MS2 phages used as internal controls [46]. Nucleic acids
extraction was performed using the EZ1 Virus Mini Kit
v2.0 and the EZ1 Advanced XL Biorobot (both from
Qiagen). The final elution volume was 90 μL.
HRV molecular diagnosis
i) Taqman probe assay: a real-time one-step RT-PCR
reaction was performed using the iScriptTM
One-Step RT-PCR Kit (Biorad) and the Biorad
CFX96 Real time System thermocycler. The 30 μL
final reaction volume contained 10 μL of viral RNA,
0.3 μM of each primer (forward 1: WGCCYGCGT
GGCKGCC, forward 2: AGCCYGCGTGGTGCCC;
reverse: GAAACACGGACACCCAAAGTAGT) and
0.1 μM of specific probe (6FAM-CTCCGGCCCCT
GAATGYGGCTAA-TAMRA); thermal cycling was:
reverse transcription at 50°C for 10 min, initial
denaturation at 95°C for 5 min, followed by 40
cycles of [95°C for 15 s, 60°C for 30 s]. This hospital
diagnostic assay used a standardised hybridisation
temperature and primers and probes concentrations
were optimised using a classical matrix experimental
procedure.
ii) BOXTO: the optimal concentration of BOXTO for was
determined according to the manufacurer’s
recommendation (TATAA Biocenter). In the case of the
Taqman probe assay presented above, the best results
were obtained with a 2.5 μM concentration. The
protocol adapted from Lind et al. [47] was identical to
that of the Taqman probe assay, with the addition of a
final melting curve (65°C to 95°C, with an increase of
0.5°C every 5 s), visualised in the “HEX” reading canal.
iii)SYBR Green: the SYBR Green assay was conducted
using the QuantiTect SYBR® Green RT-PCR Kit and
comparable reaction parameters; thermal cycling
was: reverse transcription at 50°C for 30 min, initial
denaturation at 95°C for 15 min, followed by 40
cycles of [95°C for 15 s, 60°C for 30 s and 72°C for
30 s], and a final step with a melting visualised in
the “HEX” reading canal.5′NCR sequencing
5′NCR PCR products were purified (QIAquick Gel
Extraction, QIAGEN). The 215 bp DNA products were
tagged and analysed using the Ion Torrent NGS technol-
ogy without any further fragmentation. Sequencing data
were analysed using to the CLC Genomics Workbench
bioinformatic software [48].
Structural analysis of Taqman probe
The on-line software M-fold v3.2 was used to predict the
secondary structure of the Taqman probe sequence [49].
Statistical analysis
Statistical analysis was performed using the IBM SPSS
Statistics software in this study.
Results
Between March 2011 and February 2012, 5,627 respira-
tory samples were received for detection of respiratory
virus infections and analysed in this study.
i) Taqman probe/BOXTO assay:
Using the assay that combined a probe detection
and a BOXTO detection:
– The Taqman probe identified 696 out of 5,627
samples (12,4%) as HRV positive ([P+] samples).
– The BOXTO intercalating agent detected all of
the 696 [P+] samples with a specific melting
curve peak between 84 and 86.5°C ([P + B+]
samples). However, 1,913 out of the 4,931 [P-]
samples also provided positive BOXTO results
(total [B+]: 2,609 (46.3%)). A random sample of
258 PCR products from these [P-B+] samples was
submitted to sequencing: only 24.3% (55/258)
contained HRV sequences. Results are
summarised in Figure 1.
ii) SYBR Green assay:
In a random selection of 500 [B+] samples tested in
parallel with the Taqman probe and the SYBR green
assays, 183 (36.6%) were positive in both tests
([P + SG+] samples), 298 were [P-SG-], 3 were
[P + SG-] and 16 [P-SG+]. SYBR green positive
samples were associated with a melting curve peak
between 81 and 84°C.
Ion Torrent sequencing of PCR products of the 16
[P-SG+] samples allowed identification of HRV
sequences in all cases (Figure 1).
In the absence of reference test usable as a “gold
standard” for the detection of HRV, it is difficult to pro-
vide a simple robust analysis of the performances of the
different tests. In particular, there is most probably a
proportion of our HRV-negative samples that would be
identified as HRV-positive using other detection assays
Figure 1 Evaluation of molecular diagnostic systems. P: Probe; B: BOXTO; SG: SYBR Green.
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to provide a strict numbering of true and false negatives
for our tests.
Here, we have used a few simple rules to compare the dif-
ferent assays and provide estimates of their performances:
(i) We have considered that [P+] samples were true
positives, based on the considerable information
available from the literature that suggests that
probe-based real-time PCR systems are associated
with a negligible rate of false positive results.
(ii)We have considered that the sequencing of
amplicons was the reference test for determining if
PCR products detected by the BOXTO and SYBR
green intercalating agents resulted from the specific
amplification of HRV genomes.
Accordingly, when the Taqman probe assay was com-
pared with the SYBR Green assay, a total of 202 “true
positive” samples was detected: 186 (92.1%) by the probe
assay and 199 (94.9%) by the SYBR Green assay and
confirmed by sequencing). Whatever the definition of
“negatives”, this means that the sensitivity of the SYBR
Green assay is better than that of the probe-based assay.
As sequencing of SYBR Green amplicons did not iden-
tify any false positive, this also means that the specificity
and positive predictive value of the SYBR Green assay
are 100% in the sample investigated.
When the Taqman probe assay was compared with the
BOXTO assay, 696 “true positive” samples were detectedby the probe assay but a number of additional positives
were detected by the BOXTO assay (of which an esti-
mate of 24.3% were true positives, based on sequencing
experiments). Whatever the definition of “negatives”,
this means that the sensitivity of the BOXTO assay is
better than that of the probe-based assay. However, se-
quencing of BOXTO amplicons from [P-B+] samples
provided paradoxical results:
– it evidenced a large proportion (~75%) of false
positives, which means that the specificity and
positive predictive value of the BOXTO assay would
be very low in the sample investigated (estimates
are <70% and <50%, respectively, hypothesising the
absence of false negative results).
– the proportion of confirmed positives (~25%)
indicates that a significant proportion of HRV
positive samples are not detected by the probe-
based assay.
It was interesting to analyse the sequence correspond-
ing to the probe in amplicons from [P-B+] and [P-SG+]
samples. Interestingly, the alignment of 11 HRV se-
quences from [P-B+] samples showed only 3 single sub-
stitutions located in the region targeted by the probe, at
position 8 (C→T), 15 (T→ C), and 20 (C→T) respect-
ively, whilst the remaining 8 sequences were identical to
the expected sequence.
Similarly, alignment of 16 [P-SG+] sequences identi-
fied only one modified sequence in the region targeted
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quences being identical to the expected sequence.
This suggested that different mechanisms could con-
tribute to the inefficient probe-based detection of some
HRV sequences. Besides the plausible role of specific
mutations in the region targeted by the probe, other
mechanisms, obviously independent from this sequence
occurred. Using the on-line software M-fold v3.2, the
secondary structure of the Taqman probe sequence was
determined and showed a “loop-step” conformation
(Figure 2), which may hamper the hybridisation process.Discussion
Despite the importance of ARIs in terms of morbidity as
well as infant mortality, microbiological aetiologies of
acute respiratory infections represent a complex, which
has yet to be fully characterized in developed countries
and remains largely unknown in developing countries.
Dual viral infections are common, and a large proportion
of children have evidence of viral-bacterial co-infection. In
adults, viruses are the putative causative agents in a third
of cases of community-acquired pneumonia, in particular
influenza viruses, rhinoviruses, and coronaviruses [50].
Accordingly, much better characterization of the epidemi-
ology of ARIs is still needed to improve understanding of
the role of the different pathogens and of bacterial-viral
interaction in the pathogenesis of ARIs. Since human rhi-
noviruses represent the most frequent cause of ARIsFigure 2 Predicted secondary structure of probe sequence,
using the M-fold v3.2 on-line software.worldwide and in all age groups, improving the biological
diagnosis of rhinoviral infections is a crucial issue.
In this study, we have tested and compared three dif-
ferent HRV molecular diagnostic assays. First, it is obvi-
ous that a proportion of samples truly infected by HRVs
could not be detected using the Taqman probe test. This
is evidenced by a number of probe-negative/BOXTO
positive and probe-negative/SYBR green positive sam-
ples for which the presence of HRV amplicons was con-
firmed by direct sequencing of the PCR products. This
phenomenon was shown to be highly reproducible and
the same HRV positive samples were repeatedly detect-
able or undetectable using the probe-based assay (data
not shown). Since all assays used the same amplification
primers, the most likely explanation is a default in probe
hybridisation. Analysis of the genomic sequence of HRVs
that could not be detected by the probe-based assay
showed that only a limited proportion of strains had
mutations in the probe hybridisation region. Other
mechanism(s) must therefore take place to explain the
default of hybridisation of the probe. A possible explan-
ation may lie in the highly structured form of the rhino-
viral 5”NCR, which contains an Internal Ribosome Entry
Site (IRES). On the one hand, the probe hybridisation
region itself is located in a stem-loop region, and on the
other hand mutations in different parts of the NCR may
modify the secondary structure of the genomic RNA
molecule and possibly limit the access to the probe hy-
bridisation region, as previously reported [51]. This is, to
our knowledge a rare example of inefficient probe-based
detection that is not related to mutations in the probe
hybridisation genomic region.
Second, as a number of HRV positive samples that
could not be detected using a probe-based assay were
identified by DNA-dye-complexes (using BOXTO or
SYBR green molecules), it is interesting to consider the
performances of these assays. Ideally, the probe-based
detection and the intercalating agent-based reaction
should be performed in the same reaction tube and de-
tected in distinct reading canals. This is what was
attempted by combining a FAM-TAMRA labelled probe
and BOXTO. This system allowed the detection of a
proportion of probe-negative samples, but the propor-
tion of false positive results was so high that the use of
this assay is not possible for clinical or epidemiological
purposes (unacceptably low estimated specificity and
positive predictive values). It remains from this experi-
ment the important information that a significant propor-
tion of Taqman-negative samples provided true positive
results using the same primers and the BOXTO intercalat-
ing agent. Accordingly, we tested a number of BOXTO-
positive samples using a standard Taqman assay and
(separately) a standard SYBR green assay. The SYBR
green assay was able to provide positive results in
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observed with BOXTO, were all confirmed by direct se-
quencing of amplicons, indicating that the SYBR green
assay is associated with high specificity and positive
predictive values. However, the assay failed to detect a
few probe-positive samples. Finally, we investigated a
new experimental procedure by combining the SYBR
Green and a Texas-Red labelled probe. Preliminary ex-
periments on 30 respiratory samples showed that the
level of interference between Texas red-based and
SYBR Green-based detections in a combined assay was
lower than previously observed in the case of the
couple (FAM-Boxto), but still an obstacle to routine
use: (i) in 13samples testing negative using the probe or
the SYBR Green alone, a combination of Probe + SG
provided 11 P-SG- samples and 2 P + SG- samples (e.g.,
2 false positives in 13 negative samples tested, which is
too high for diagnostic use, but much lower than with
the couple FAM-Boxto (circa 75%)); (ii) in 17 samples
testing positive using the probe or the SG alone, the
combination of Probe + SG provided 16 P + SG + sam-
ples and one P-SG + sample. The mean detection CT
was slightly increased when detection was performed in
the presence of SYBR Green and this was sufficient to
make negative using the combined assay one sample
that tested positive using the probe alone.
This final experiment reinforces the idea that it should
be possible to decrease the level of interference between
the probe-based and intercalating agent-based detection
systems and the next steps should include a systematic
investigation of the possible combinations that may
allow to identify a couple usable for diagnostic purposes.
Conclusion
In conclusion, this study confirms the difficulty in detecting
HRVs in clinical samples using a single molecular detection
system. Besides the possible utilisation of distinct pairs of
primers to adequately cover the natural genetic diversity of
HRV isolates [46] our results suggest that the optimisation
of the detection of amplicons produced by primers is an
important issue. In our hands, a SYBR green-based assay
was slightly more sensitive that a Taqman probe-based
assay and constituted the best compromise amongst the
techniques tested. Attempts to associate a probe-based de-
tection with an intercalating agent-based detection should
be renewed to identify a reliable couple (DNA dye/probe
label) that could be used for routine diagnostic and epi-
demiological detection of human rhinoviruses.
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